CHUNLI MEDICAL(SH:688236) Shang Hai Zheng Quan Bao·2025-11-19 18:04Core Viewpoint - The company held its first extraordinary general meeting and the second A-share class shareholders' meeting in 2025, with significant resolutions passed, including the proposal to cancel the supervisory board and amend the company's articles of association, which requires further approval from the second H-share class shareholders' meeting [2][10]. Meeting Details - The second A-share class shareholders' meeting was held on November 19, 2025, at a specified location in Beijing [3]. - The second H-share class shareholders' meeting was postponed to December 3, 2025, due to insufficient voting rights from H-share holders [2][3]. Attendance and Voting - All 8 current directors and 3 supervisors attended the meetings, utilizing both in-person and communication methods for participation [5][6]. - The voting method combined on-site and online voting, complying with relevant laws and regulations [4]. Resolutions Passed - The following proposals were approved: - Proposal to cancel the supervisory board and amend the articles of association [6][8]. - Proposal to amend the shareholders' meeting rules [7]. - Proposal to amend the board of directors' rules [7]. - Proposal for the profit distribution plan for the first three quarters of 2025 [8]. - The approval of the supervisory board cancellation proposal is contingent upon the outcome of the second H-share class shareholders' meeting [6][10]. Legal Compliance - The meetings were witnessed by a law firm, confirming that the procedures, attendance, and voting results complied with the Company Law and relevant regulations [10].